The modern landscape of psychiatric medicine is experiencing a profound renaissance, driven by the re-examination of classical psychedelics in treating intractable mental health conditions. Across international jurisdictions spanning the United States, Canada, Brazil, Mexico, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, and Switzerland, clinical researchers and neuroscientists are intensely evaluating the therapeutic utility […]